Same mission. Same team. Stronger platform for life sciences, diagnostics, and combination drug product customers. Carlsbad, CA — September 8, 2026 — Argonaut Manufacturing Services today announced that its life sciences, diagnostics, and combination drug […]
**EVENT IS SOLD OUT. WE WILL NOT BE ACCEPTING ONSITE REGISTRATIONS, NO EXCEPTIONS. YOU WILL NEED AN EXISTING PAID REGISTRATION TO ATTEND.** Biotech Networks is back with in person events June 23rd in downtown […]
GemPharmatech Significantly Expands U.S. Capabilities with New San Diego Biotech Hub Facility Comprehensive laboratory and rodent vivarium enhances preclinical research infrastructure in North America. SAN DIEGO, CA — April 17, 2025 — GemPharmatech, a global […]
[San Diego, CA – March 25, 2025] – V2 Clinical, a leader in pharmaceutical and biotech services, today announced the launch of V2 aiHuman, an advanced AI/ML-powered platform that revolutionizes preclinical drug development. By accelerating […]
Biotech Networks is hosting Scientific Speed Networking in San Diego Tuesday December 10th 2024, it’s a great chance for life science professionals to make connections before the holidays. We’ll be back at Come On […]
Biotech Networks’ 2023/2024 US tour heads back “home” to San Diego November 7th 2023. We’ll be back at the Come On In! Cafe Torrey Pines, where we’ll network amongst the actual Torrey Pines trees! We […]
Is AI dictating patient care? What happens when your bank falls apart? And can Illumina endure some shareholder activism? We cover all that and more this week on the 250th episode of “The Readout LOUD,” […]
Illumina, the DNA sequencing giant whose stock has fallen 40% in two years, already had problems. Now it has to contend with Carl Icahn. The granddaddy of activist investors announced Monday morning that he’s taken […]
SAN DIEGO — The first time it happened, veteran real estate broker Ted Jacobs thought it was a fluke. But it didn’t take long for him to realize that the biotech industry’s demand for lab […]
Sanofi’s head of research and development, John Reed, is leaving the pharmaceutical giant to pursue a new opportunity, the company announced Monday. Reed joined Sanofi in 2018, after holding a similar position at Swiss pharma […]
Illumina, the largest maker of DNA sequencing technology, told investors exactly what they didn’t want to hear on Monday. For years, Illumina shares rose steadily as the company led the way on pushing down the […]
SAN DIEGO — Fate Therapeutics, a biotech upstart with big ambitions to use cell-based therapies to treat autoimmune diseases and cancer, is now planning to cut back on both jobs and experimental drugs after an […]
Biosplice’s bid to transform the treatment of everything from arthritis to cancer ran into a snag this week, with the San Diego biotech announcing that its experimental osteoarthritis drug failed to benefit patients in a […]
CARLSBAD, Calif. — Biotech companies developing cutting-edge cell and gene therapies often are tripped up by how much regulations around these drugs vary from country to country. On Wednesday, regulators from the United States, the […]
SAN DIEGO — After a steep drop in its stock price and with mounting competition from rivals, genomics giant Illumina on Thursday launched a new line of high-powered DNA sequencers, ratcheting up the race to […]
Is Illumina a victim of its own success? What makes the FDA change its mind? And how will petrodollars change biotech? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech […]
For Illumina, the leading maker of DNA sequencing equipment, there was bad news and worse news Tuesday. The bad news: The European Commission said it was blocking Illumina’s $8 billion acquisition of Grail, a firm […]
SAN DIEGO — Sequencing behemoth Illumina on Thursday won its case against the Federal Trade Commission in its bid to hold onto Grail, a Bay Area early cancer detection company that the genomics giant acquired […]
SAN DIEGO — From San Diego to New Jersey, biotechs developing new forms of birth control say they’re doubling down on those efforts after Roe v. Wade was overturned — even as the Supreme Court’s […]
SAN DIEGO — More than 40 years ago, Ivor Royston, a brash young assistant professor at University of California, San Diego, made an odd pitch to scientists and pharmaceutical executives across the country: Ditch your […]
Two months after being sued by Illumina over the alleged theft of trade secrets, Bay Area biotech Guardant Health fired back this week, rejecting the DNA sequencing giant’s claims and asking a federal judge to […]
DNA sequencing giant Illumina announced Thursday that it would enter the field of drug discovery, a major shift for a company that, since its founding in 1998, has thrived instead by selling picks and shovels […]
SAN DIEGO — Bay Area biotech Guardant Health is closer than ever to its ultimate goal — developing and deploying a simple, blood-based test that you could get during an annual doctor’s visit to spot […]
San Diego biotech Halozyme announced Wednesday that it plans to buy drug development and delivery firm Antares Pharma for about $960 million. The deal, expected to go through by the first half of this year, […]
If it wasn’t for a well-placed ad in the paper, Rob Perez might not have found his way to the life sciences industry. As he’ll tell you, he wasn’t on the traditional path to becoming […]
SAN DIEGO — If you’d seen him, you wouldn’t have known Scott Lippman was living through one of the most harrowing days of his 35-year career. The veteran oncologist, who directs UC San Diego’s Moores […]
DNA sequencing giant Illumina is suing Guardant Health, a firm that has become both its customer and rival, claiming that the patents at the core of Guardant’s quest to detect cancer with a simple blood […]
Biotech Networks, the premier life science organization catalyzing connections between thousands of professionals in the field globally, is hosting the first virtual career fair focused on improving diversity in California’s life science industry. Biotech Networks […]
***If you’re attending the event, watch the instructional videos and see the schedule and other tips by clicking here*** After 10 years providing the San Diego biotech community with our patented speed networking events, the current […]
Inducible pluripotent stem cells (iPSCs) are cultured cells with the ability to become any cell type present in the species from which it came. Jeanne Loring (Professsor Emeritus at Scripps Research and the Chief Scientific […]
Copyright © 2026 Biotech Networks, LLC
